These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7486485)

  • 1. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial.
    Toft I; Bønaa KH; Ingebretsen OC; Nordøy A; Jenssen T
    Ann Intern Med; 1995 Dec; 123(12):911-8. PubMed ID: 7486485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
    Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
    Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.
    Annuzzi G; Rivellese A; Capaldo B; Di Marino L; Iovine C; Marotta G; Riccardi G
    Atherosclerosis; 1991 Mar; 87(1):65-73. PubMed ID: 1872925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study.
    Bønaa KH; Bjerve KS; Straume B; Gram IT; Thelle D
    N Engl J Med; 1990 Mar; 322(12):795-801. PubMed ID: 2137901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
    Qin Y; Zhou Y; Chen SH; Zhao XL; Ran L; Zeng XL; Wu Y; Chen JL; Kang C; Shu FR; Zhang QY; Mi MT
    PLoS One; 2015; 10(7):e0133496. PubMed ID: 26226139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
    Dorella M; Giusto M; Da Tos V; Campagnolo M; Palatini P; Rossi G; Ceolotto G; Felice M; Semplicini A; Del Prato S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1568-74. PubMed ID: 8636369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
    Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
    Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial.
    Wang F; Wang Y; Zhu Y; Liu X; Xia H; Yang X; Sun G
    Eur J Nutr; 2017 Oct; 56(7):2415-2422. PubMed ID: 27913872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation.
    Mostad IL; Bjerve KS; Bjorgaas MR; Lydersen S; Grill V
    Am J Clin Nutr; 2006 Sep; 84(3):540-50. PubMed ID: 16960167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
    Mori TA; Burke V; Puddey IB; Watts GF; O'Neal DN; Best JD; Beilin LJ
    Am J Clin Nutr; 2000 May; 71(5):1085-94. PubMed ID: 10799369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.
    Luo J; Rizkalla SW; Vidal H; Oppert JM; Colas C; Boussairi A; Guerre-Millo M; Chapuis AS; Chevalier A; Durand G; Slama G
    Diabetes Care; 1998 May; 21(5):717-24. PubMed ID: 9589230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
    Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
    Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure lowering in elderly subjects: a double-blind crossover study of omega-3 and omega-6 fatty acids.
    Margolin G; Huster G; Glueck CJ; Speirs J; Vandegrift J; Illig E; Wu J; Streicher P; Tracy T
    Am J Clin Nutr; 1991 Feb; 53(2):562-72. PubMed ID: 1989427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Double-Blinded, Placebo-Controlled Trial Investigating the Effect of Fish Oil Supplementation on Gene Expression Related to Insulin Action, Blood Lipids, and Inflammation in Gestational Diabetes Mellitus-Fish Oil Supplementation and Gestational Diabetes.
    Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Taghizadeh M; Asemi Z
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial.
    Radack K; Deck C; Huster G
    Arch Intern Med; 1991 Jun; 151(6):1173-80. PubMed ID: 1828336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention.
    Sacks FM; Hebert P; Appel LJ; Borhani NO; Applegate WB; Cohen JD; Cutler JA; Kirchner KA; Kuller LH; Roth KJ
    J Hypertens; 1994 Feb; 12(2):209-13. PubMed ID: 8021472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia.
    Grundt H; Nilsen DW; Hetland O; Aarsland T; Baksaas I; Grande T; Woie L
    J Intern Med; 1995 Mar; 237(3):249-59. PubMed ID: 7891046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in hypertension is associated with body fat rather than blood pressure.
    Toft I; Bønaa KH; Jenssen T
    Hypertension; 1998 Jul; 32(1):115-22. PubMed ID: 9674647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A
    Am J Clin Nutr; 1997 Sep; 66(3):649-59. PubMed ID: 9280188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.